
Cloe® Select
Bespoke ADME and DMPK experimental service
Our Cloe® Select ADME and DMPK experimental service is designed to meet the requirements of later stage studies. Services include: in vitro metabolism, in vitro permeability, in vitro protein binding and physicochemical properties and PK and bioanalysis. Cloe® Select offers the following benefits:
|
Cloe® Select Services
| In vitro metabolism |
|---|
| metabolite profiling and identification |
| cytochrome P450 induction |
| cytochrome P450 Ki |
| time dependent inhibition (kinact/KI ) |
| UGT1A1 inhibition |
| In vitro permeability |
|---|
| P - glycoprotein inhibition |
| Bioanalysis |
|---|
| bioanalytical method development and validation |
| Physicochemical properties |
|---|
| pKa and log P determination |
| Protein binding |
|---|
| brain tissue binding |
| blood to plasma ratio |
Additional services are available under Cloe® Screen
Can't see the assay you need?
Please contact our Product Development Team with your requirements.

Genomic ADME - gADME™
Cyprotex's proprietary gADME™ system can alert you to genetic variations in drug metabolism, allowing for personalised doses, drug rescue and repositioning.
Learn more about gADME
In vitro Micronucleus Test
Cyprotex now offers the in vitro micronucleus test for genotoxicity assessment using an automated, high content screening method for improved detection and reliability.
Learn more about our in vitro MNT service
Drug Transporters
Cyprotex provides a full range of drug-transporter studies as recommended by the ITC white paper and EMA guidelines.
Learn more about transporters

By Dr. Katya Tsaioun, Chief Scientific Officer, Cyprotex
Wiley & Sons, March 2011






